Literature DB >> 15531515

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.

Filomena Cetani1, Elena Pardi, Simona Borsari, Paolo Viacava, Giada Dipollina, Luisella Cianferotti, Elena Ambrogini, Elisabetta Gazzerro, Giacomo Colussi, Piero Berti, Paolo Miccoli, Aldo Pinchera, Claudio Marcocci.   

Abstract

We investigated the involvement of the HRPT2 gene by loss of heterozygosity analysis and direct sequencing in a kindred with hyperparathyroidism-jaw tumor syndrome (HPT-JT) and three kindreds with familial isolated primary hyperparathyroidism (FIHP). Seven patients with sporadic parathyroid cancers and 35 with parathyroid adenomas with no family history of primary hyperparathyroidism or HPT-JT were also studied. A germline heterozygous substitution G to A was found in the donor splice site of intron 1 in one of the three FIHP families. No mutations were identified in the HPT-JT kindred. A somatic HRPT2 mutation was found in four of seven patients with parathyroid cancers, two of which were unreported frameshift mutations (195insT and 195insA) in exon 2. Consistent with recent findings, two of seven patients with sporadic parathyroid cancer had germline mutations. Four adenomas showed loss of heterozygosity at HRPT2, whereas a somatic HRPT2 mutation was found in one. In conclusion, we provide additional evidence for a strong association between HRPT2 gene mutations and sporadic parathyroid cancer. The finding that two of the seven patients with sporadic parathyroid cancer carried an HRPT2 germline mutation suggests that they might have occult HPT-JT. Our results also confirm the need for testing HRPT2 gene in FIHP families.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531515     DOI: 10.1210/jc.2004-0294

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  73 in total

1.  Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73.

Authors:  J-H Zhang; L M Panicker; E M Seigneur; L Lin; C D House; W Morgan; W C Chen; H Mehta; M Haj-Ali; Z-X Yu; W F Simonds
Journal:  Cell Death Differ       Date:  2010-03-26       Impact factor: 15.828

2.  Parafibromin and APC as screening markers for malignant potential in atypical parathyroid adenomas.

Authors:  C Christofer Juhlin; Inga-Lena Nilsson; Kenth Johansson; Felix Haglund; Andrea Villablanca; Anders Höög; Catharina Larsson
Journal:  Endocr Pathol       Date:  2010-09       Impact factor: 3.943

Review 3.  Immunohistochemistry in Diagnostic Parathyroid Pathology.

Authors:  Lori A Erickson; Ozgur Mete
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

4.  [Prophylactic parathyroidectomy for familial parathyroid carcinoma].

Authors:  O Gimm; K Lorenz; P Nguyen Thanh; U Schneyer; M Bloching; V M Howell; D J Marsh; B T Teh; U Krause; H Dralle
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 5.  Understanding the genetic basis of parathyroid carcinoma.

Authors:  Anthony J Gill
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

6.  Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.

Authors:  Jessica Costa-Guda; Yasuo Imanishi; Nallasivam Palanisamy; Norihiko Kawamata; H Phillip Koeffler; R S K Chaganti; Andrew Arnold
Journal:  Endocrine       Date:  2013-02-24       Impact factor: 3.633

7.  [Disseminated osteolytic lesions in a 28-year-old refugee].

Authors:  T Karrasch; H D Walmrath; M Kampschulte; D Steiner; W Seeger; W Padberg; U Sibelius; S Gattenlöhner; A Schäffler
Journal:  Internist (Berl)       Date:  2018-05       Impact factor: 0.743

8.  EZH2 copy number and mutational analyses in sporadic parathyroid adenomas.

Authors:  Robert Romano; Chen-Pang Soong; Madison Rose; Jessica Costa-Guda; Justin Bellizzi; Andrew Arnold
Journal:  Endocrine       Date:  2016-10-14       Impact factor: 3.633

Review 9.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

10.  The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene.

Authors:  Ling Lin; Jian-Hua Zhang; Leelamma M Panicker; William F Simonds
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.